• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

破坏细胞防御系统的纳米颗粒作为增强化疗治疗耐药性癌症的平台。

Cellular defense system-destroying nanoparticles as a platform for enhanced chemotherapy against drug-resistant cancer.

机构信息

School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou 510006, China.

College of Pharmacy, Jinan University, Guangzhou 510632, China.

出版信息

Mater Sci Eng C Mater Biol Appl. 2021 Dec;131:112494. doi: 10.1016/j.msec.2021.112494. Epub 2021 Oct 18.

DOI:10.1016/j.msec.2021.112494
PMID:34857280
Abstract

Cellular defense system represented by glutathione (GSH) greatly weakens the outcomes of cancer therapy by antioxidation and detoxification. GSH depletion has been proved to be an effective way to enhance the efficacy of reactive oxygen species (ROS)-based therapies and chemotherapy. However, the existing strategies of GSH depletion still face the problems of unclear biosafety and high complexity of multicomponent co-delivery. In this study, we developed a GSH-depleting carrier platform based on disulfide-bridged mesoporous organosilica nanoparticles (MONs) to destroy the cellular defense system for cancer therapy. Responding to the high level of GSH in cancer cells, the disulfide bonds in the framework of MONs could be broken and consumed substantial GSH at the same time. Moreover, this process also promoted the degradation of MONs. In order to evaluate the effect of this platform in cancer therapy, chemotherapeutic drug cisplatin was loaded into MONs (Pt@MONs) to treat drug-resistant non-small cell lung cancer. In vitro and in vivo results indicated that Pt@MONs efficiently triggered GSH depletion, promoted platinum-DNA adduct formation, and induced cell apoptosis, resulting in significant tumor growth inhibition without marked toxicity. Taken together, the cellular defense system-destroying nanoparticles provide a promising platform for enhanced cancer therapy.

摘要

细胞防御系统,由谷胱甘肽(GSH)代表,通过抗氧化和解毒作用极大地削弱了癌症治疗的效果。已证实 GSH 耗竭是增强基于活性氧(ROS)的治疗和化学疗法疗效的有效方法。然而,现有的 GSH 耗竭策略仍然面临着生物安全性不明确和多组分共递复杂性高的问题。在这项研究中,我们开发了一种基于二硫键桥联介孔有机硅纳米粒子(MONs)的 GSH 耗竭载体平台,以破坏细胞防御系统进行癌症治疗。针对癌细胞中高水平的 GSH,MONs 中的二硫键可以被破坏,并同时消耗大量的 GSH。此外,这个过程还促进了 MONs 的降解。为了评估该平台在癌症治疗中的效果,将化疗药物顺铂装载到 MONs 中(Pt@MONs)以治疗耐药性非小细胞肺癌。体外和体内结果表明,Pt@MONs 能够有效地触发 GSH 耗竭,促进铂-DNA 加合物的形成,并诱导细胞凋亡,从而显著抑制肿瘤生长,而没有明显的毒性。总之,破坏细胞防御系统的纳米颗粒为增强癌症治疗提供了一个有前途的平台。

相似文献

1
Cellular defense system-destroying nanoparticles as a platform for enhanced chemotherapy against drug-resistant cancer.破坏细胞防御系统的纳米颗粒作为增强化疗治疗耐药性癌症的平台。
Mater Sci Eng C Mater Biol Appl. 2021 Dec;131:112494. doi: 10.1016/j.msec.2021.112494. Epub 2021 Oct 18.
2
A comparison of mesoporous silica nanoparticles and mesoporous organosilica nanoparticles as drug vehicles for cancer therapy.介孔硅纳米粒子和介孔有机硅纳米粒子作为癌症治疗药物载体的比较。
Chem Biol Drug Des. 2018 Aug;92(2):1435-1444. doi: 10.1111/cbdd.13309. Epub 2018 May 12.
3
Coordination and Redox Dual-Responsive Mesoporous Organosilica Nanoparticles Amplify Immunogenic Cell Death for Cancer Chemoimmunotherapy.介孔有机硅纳米粒子的协调和氧化还原双重响应增强免疫原性细胞死亡用于癌症化疗免疫治疗。
Small. 2021 Jul;17(26):e2100006. doi: 10.1002/smll.202100006. Epub 2021 Jun 3.
4
"Pincer movement": Reversing cisplatin resistance based on simultaneous glutathione depletion and glutathione -transferases inhibition by redox-responsive degradable organosilica hybrid nanoparticles.“钳形运动”:基于氧化还原响应性可降解有机硅杂化纳米颗粒同时消耗谷胱甘肽和抑制谷胱甘肽转移酶来逆转顺铂耐药性
Acta Pharm Sin B. 2022 Apr;12(4):2074-2088. doi: 10.1016/j.apsb.2021.10.013. Epub 2021 Oct 21.
5
Tumor Acidic Microenvironment Targeted Drug Delivery Based on pHLIP-Modified Mesoporous Organosilica Nanoparticles.基于 pHLIP 修饰的介孔有机硅纳米粒子的肿瘤酸性微环境靶向药物递送
ACS Appl Mater Interfaces. 2017 Sep 13;9(36):30543-30552. doi: 10.1021/acsami.7b10840. Epub 2017 Aug 29.
6
Ultrasmall mesoporous organosilica nanoparticles: Morphology modulations and redox-responsive biodegradability for tumor-specific drug delivery.超小介孔有机硅纳米粒子:形态调节和氧化还原响应生物降解性用于肿瘤特异性药物传递。
Biomaterials. 2018 Apr;161:292-305. doi: 10.1016/j.biomaterials.2018.01.046. Epub 2018 Feb 3.
7
Functionalization of mesoporous organosilica nanocarrier for pH/glutathione dual-responsive drug delivery and imaging of cancer therapy process.介孔有机硅纳米载体的功能化用于 pH/谷胱甘肽双重响应药物递送和癌症治疗过程的成像。
Talanta. 2018 Jan 15;177:203-211. doi: 10.1016/j.talanta.2017.07.017. Epub 2017 Jul 13.
8
Nanosilver-Decorated Biodegradable Mesoporous Organosilica Nanoparticles for GSH-Responsive Gentamicin Release and Synergistic Treatment of Antibiotic-Resistant Bacteria.载银生物降解介孔有机硅纳米粒子用于 GSH 响应性庆大霉素释放及协同治疗耐药菌。
Int J Nanomedicine. 2021 Jul 6;16:4631-4642. doi: 10.2147/IJN.S315067. eCollection 2021.
9
Biodegradable Materials with Disulfide-Bridged-Framework Confine Photosensitizers for Enhanced Photo-Immunotherapy.具有二硫键桥连骨架的可生物降解材料限制光敏剂用于增强光免疫治疗。
Int J Nanomedicine. 2021 Dec 24;16:8323-8334. doi: 10.2147/IJN.S344679. eCollection 2021.
10
Cisplatin and doxorubicin high-loaded nanodrug based on biocompatible thioether- and ethane-bridged hollow mesoporous organosilica nanoparticles.基于生物相容性硫醚和乙烷桥联的中空介孔有机硅纳米粒子的顺铂和阿霉素高载药纳米药物。
J Colloid Interface Sci. 2018 Mar 1;513:214-221. doi: 10.1016/j.jcis.2017.10.116. Epub 2017 Nov 2.

引用本文的文献

1
Oxidative Stress Defense Module in Lung Cancers: Molecular Pathways and Therapeutic Approaches.肺癌中的氧化应激防御模块:分子途径与治疗方法
Antioxidants (Basel). 2025 Jul 13;14(7):857. doi: 10.3390/antiox14070857.